Related Experiment Video
Updated: May 24, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
The effect of ankaferd to stop bleeding in experimental partial nephrectomy
F R Yalcinkaya1, M Kerem, E O Guven
1Mustafa Kemal University Faculty of Medicine Urology Department, Hatay, Turkey, Gazi University, Medical Faculty, Ankara, Turkey. drfatihyalcinkaya@hotmail.com
This study evaluates the effectiveness of a traditional Turkish herbal extract, Ankaferd, in controlling bleeding during kidney surgery in a rat model. Researchers compared this substance against standard surgical materials to determine its impact on blood loss and kidney function. The findings suggest that this agent significantly reduces bleeding without causing adverse effects on renal health markers.
Area of Science:
- Urological surgery outcomes research within Ankaferd blood stopper medicine
- Experimental renal physiology and trauma management
Background:
Excessive hemorrhage remains a primary complication during renal procedures, necessitating effective hemostatic interventions. Traditional medical practices often utilize plant-based extracts to manage traumatic injuries. However, rigorous scientific validation of these substances in modern surgical settings is frequently lacking. Prior research has shown that various synthetic materials are standard for achieving local hemostasis. That uncertainty drove the investigation into alternative agents derived from historical medicinal applications. No prior work had resolved the comparative efficacy of this specific herbal preparation in partial nephrectomy models. This gap motivated the current assessment of its performance against established clinical standards. Investigators sought to determine if traditional remedies could offer a viable substitute for conventional hemostatic tools.
Purpose Of The Study:
The study aimed to evaluate the efficacy of a traditional herbal extract in controlling bleeding during partial nephrectomy. Researchers sought to determine if this substance could serve as a reliable hemostatic agent. The investigation addressed the challenge of managing hemorrhage in complex renal surgical procedures. By comparing the extract to standard materials, the team aimed to validate its clinical potential. This work was motivated by the need for effective, safe alternatives in modern urological practice. The researchers hypothesized that the traditional remedy would provide significant benefits in reducing blood loss. They designed the experiment to ensure rigorous comparison against existing surgical standards. The primary goal remained the assessment of both safety and performance in a controlled animal model.
Main Methods:
The research team utilized twenty-four Wistar-Albino rats to conduct this controlled experimental study. Subjects were divided into four distinct groups to evaluate different hemostatic approaches. The first cohort served as a sham control, undergoing only a laparotomy procedure. The second group received saline solution following the removal of the lower kidney pole. A third group was treated with Surgycell to manage the surgical site. The final group received the herbal extract to assess its performance in stopping hemorrhage. Researchers weighed gauze on a sensitive scale before and after the operation to quantify total blood loss. Finally, the team monitored blood urea, creatinine, and tissue samples five hours after the intervention.
Main Results:
The application of the herbal extract resulted in a significant reduction in total blood loss compared to other groups. Statistical analysis confirmed that the fourth group experienced the lowest hemorrhage volume among all cohorts. No meaningful differences emerged regarding blood urea levels across the four experimental conditions. Creatinine concentrations remained stable, showing no significant variation between the treated and control subjects. Histopathological evaluations revealed no damage to the renal tissue in any of the tested groups. The saline-treated group showed no improvement in bleeding control compared to the sham procedure. Surgycell provided a baseline for comparison, but the herbal extract demonstrated superior performance in this specific model. These findings indicate that the agent effectively manages acute bleeding without compromising renal safety markers.
Conclusions:
The authors propose that this herbal agent serves as an effective tool for managing acute hemorrhage during renal operations. Their data suggest that the substance significantly lowers blood loss compared to untreated controls. The researchers note that renal function markers remained stable across all experimental cohorts. Histopathological assessments indicated no adverse tissue changes resulting from the application of the agent. These findings imply that the substance does not interfere with normal kidney recovery processes. The study highlights the potential for integrating traditional medicine into modern surgical protocols. Future clinical applications may benefit from the observed hemostatic properties of this specific extract. The evidence supports the utility of this agent as a reliable option for surgeons performing partial nephrectomies.
Frequently Asked Questions
The researchers propose that the agent functions as a potent hemostatic, significantly reducing blood loss during partial nephrectomy. Unlike saline, which showed no effect, this substance actively limits hemorrhage in the surgical field.
The study utilizes Ankaferd, a traditional Turkish herbal extract, as the primary hemostatic agent. This is compared against Surgycell, a standard synthetic material, and a saline control group to assess relative performance.
A partial nephrectomy model in Wistar-Albino rats was necessary to simulate clinical surgical conditions. This approach allowed for controlled, standardized trauma to the lower kidney pole, ensuring accurate measurement of blood loss.
Gauze weight measurements provided the quantitative data for blood loss. By weighing the material before and after the procedure, the team calculated the precise volume of hemorrhage for each subject.
The team measured blood urea and creatinine levels five hours post-operation. These markers were analyzed alongside histopathological tissue samples to ensure the agent did not cause systemic or local renal toxicity.
The researchers propose that this agent is a viable alternative for controlling acute bleeding in kidney surgery. They suggest its efficacy is comparable to or better than standard synthetic materials currently used in clinical practice.

